As of Jul 31
| +0.16 / +4.82%|
The 2 analysts offering 12-month price forecasts for Metabolix Inc have a median target of 3.30, with a high estimate of 3.60 and a low estimate of 3.00. The median estimate represents a -5.17% decrease from the last price of 3.48.
The current consensus among 2 polled investment analysts is to Hold stock in Metabolix Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.